It has been reported that cells expressing CD44 [27] and aldehyde dehydrogenase (ALDH) activity [28] in head and neck squamous cell carcinoma (HNSCC) exhibit cancer stem cell (CSC)-like properties. This evidence concerns the gene CD44 and head and neck squamous cell carcinoma.